Mechanically, inhibition of BRD4 sensitized NSCLC cells to osimertinib by blocking YAP1-mediated APT1 transcription and disrupting APT1-mediated depalmitoylation of MST1 and YAP1 nuclear translocation. Here, LYPLA1 is linked to non-small cell lung carcinoma.